Big Data Analytics for Genomic Medicine

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2017 Feb 18

PMID 28212287

Citations 46

Authors

Karen Y He

Dongliang Ge

Max M He

Affiliations

Soon will be listed here.

Abstract

Genomic medicine attempts to build individualized strategies for diagnostic or therapeutic decision-making by utilizing patients' genomic information. Big Data analytics uncovers hidden patterns, unknown correlations, and other insights through examining large-scale various data sets. While integration and manipulation of diverse genomic data and comprehensive electronic health records (EHRs) on a Big Data infrastructure exhibit challenges, they also provide a feasible opportunity to develop an efficient and effective approach to identify clinically actionable genetic variants for individualized diagnosis and therapy. In this paper, we review the challenges of manipulating large-scale next-generation sequencing (NGS) data and diverse clinical data derived from the EHRs for genomic medicine. We introduce possible solutions for different challenges in manipulating, managing, and analyzing genomic and clinical data to implement genomic medicine. Additionally, we also present a practical Big Data toolset for identifying clinically actionable genetic variants using high-throughput NGS data and EHRs.

Citing Articles

Big data for neuroscience in the context of predictive, preventive, and personalized medicine.

Bajinka O, Ouedraogo S, Li N, Zhan X EPMA J. 2025; 16(1):17-35.

PMID: 39991094 PMC: 11842698. DOI: 10.1007/s13167-024-00393-1.

Revolutionizing Personalized Medicine: Synergy with Multi-Omics Data Generation, Main Hurdles, and Future Perspectives.

Molla G, Bitew M Biomedicines. 2025; 12(12.

PMID: 39767657 PMC: 11673561. DOI: 10.3390/biomedicines12122750.

Application of Data Mining Technology in the Screening for Gallbladder Stones: A Cross-Sectional Retrospective Study of Chinese Adults.

Wang S, Bao C, Pei D Yonsei Med J. 2024; 65(4):210-216.

PMID: 38515358 PMC: 10973557. DOI: 10.3349/ymj.2023.0246.

New Challenges for Anatomists in the Era of Omics.

Stabile A, Pistilli A, Mariangela R, Rende M, Bartolini D, Di Sante G Diagnostics (Basel). 2023; 13(18).

PMID: 37761332 PMC: 10529314. DOI: 10.3390/diagnostics13182963.

Liquid biopsy. A challenge for clinical laboratories.

Jimenez W Adv Lab Med. 2023; 1(3):20200055.

PMID: 37361499 PMC: 10197807. DOI: 10.1515/almed-2020-0055.

References

Rasmussen-Torvik L, Stallings S, Gordon A, Almoguera B, Basford M, Bielinski S . Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems. Clin Pharmacol Ther. 2014; 96(4):482-9. PMC: 4169732. DOI: 10.1038/clpt.2014.137. View

Gurwitz D, Pirmohamed M . Pharmacogenomics: the importance of accurate phenotypes. Pharmacogenomics. 2010; 11(4):469-70. DOI: 10.2217/pgs.10.41. View

Langmead B, Schatz M, Lin J, Pop M, Salzberg S . Searching for SNPs with cloud computing. Genome Biol. 2009; 10(11):R134. PMC: 3091327. DOI: 10.1186/gb-2009-10-11-r134. View

Flanagan S, Patch A, Ellard S . Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations. Genet Test Mol Biomarkers. 2010; 14(4):533-7. DOI: 10.1089/gtmb.2010.0036. View

Laird A, Eickhoff S, Fox P, Uecker A, Ray K, Saenz Jr J . The BrainMap strategy for standardization, sharing, and meta-analysis of neuroimaging data. BMC Res Notes. 2011; 4:349. PMC: 3180707. DOI: 10.1186/1756-0500-4-349. View

Auton A, Brooks L, Durbin R, Garrison E, Kang H, Korbel J . A global reference for human genetic variation. Nature. 2015; 526(7571):68-74. PMC: 4750478. DOI: 10.1038/nature15393. View

Allen A, Cossette P, Delanty N, Eichler E, Goldstein D, Han Y . De novo mutations in epileptic encephalopathies. Nature. 2013; 501(7466):217-21. PMC: 3773011. DOI: 10.1038/nature12439. View

Fang H, Wu Y, Narzisi G, ORawe J, Barron L, Rosenbaum J . Reducing INDEL calling errors in whole genome and exome sequencing data. Genome Med. 2014; 6(10):89. PMC: 4240813. DOI: 10.1186/s13073-014-0089-z. View

Munoz M, Pong-Wong R, Canela-Xandri O, Rawlik K, Haley C, Tenesa A . Evaluating the contribution of genetics and familial shared environment to common disease using the UK Biobank. Nat Genet. 2016; 48(9):980-3. PMC: 5989924. DOI: 10.1038/ng.3618. View

10.

Raichle M . Functional brain imaging and human brain function. J Neurosci. 2003; 23(10):3959-62. PMC: 6741098. View

11.

Gulcher J, Jonsson P, Kong A, Kristjansson K, Frigge M, Karason A . Mapping of a familial essential tremor gene, FET1, to chromosome 3q13. Nat Genet. 1997; 17(1):84-7. DOI: 10.1038/ng0997-84. View

12.

Gullapalli R, Lyons-Weiler M, Petrosko P, Dhir R, Becich M, LaFramboise W . Clinical integration of next-generation sequencing technology. Clin Lab Med. 2012; 32(4):585-99. PMC: 3479671. DOI: 10.1016/j.cll.2012.07.005. View

13.

Rodrigues J, De La Torre I, Fernandez G, Lopez-Coronado M . Analysis of the security and privacy requirements of cloud-based electronic health records systems. J Med Internet Res. 2013; 15(8):e186. PMC: 3757992. DOI: 10.2196/jmir.2494. View

14.

Reiber G, LaCroix A . Older Women Veterans in the Women's Health Initiative. Gerontologist. 2016; 56 Suppl 1:S1-5. PMC: 5881618. DOI: 10.1093/geront/gnv673. View

15.

Landrum M, Lee J, Riley G, Jang W, Rubinstein W, Church D . ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2013; 42(Database issue):D980-5. PMC: 3965032. DOI: 10.1093/nar/gkt1113. View

16.

Daneshjou R, Zappala Z, Kukurba K, Boyle S, Ormond K, Klein T . PATH-SCAN: a reporting tool for identifying clinically actionable variants. Pac Symp Biocomput. 2013; :229-40. PMC: 4008882. View

17.

Abuin J, Pichel J, Pena T, Amigo J . BigBWA: approaching the Burrows-Wheeler aligner to Big Data technologies. Bioinformatics. 2015; 31(24):4003-5. DOI: 10.1093/bioinformatics/btv506. View

18.

Sanders S, Murtha M, Gupta A, Murdoch J, Raubeson M, Willsey A . De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature. 2012; 485(7397):237-41. PMC: 3667984. DOI: 10.1038/nature10945. View

19.

Dewey F, Gusarova V, ODushlaine C, Gottesman O, Trejos J, Hunt C . Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease. N Engl J Med. 2016; 374(12):1123-33. PMC: 4900689. DOI: 10.1056/NEJMoa1510926. View

20.

McCarty C, Nair A, Austin D, Giampietro P . Informed consent and subject motivation to participate in a large, population-based genomics study: the Marshfield Clinic Personalized Medicine Research Project. Community Genet. 2006; 10(1):2-9. DOI: 10.1159/000096274. View